Tue, Jun 08 | webinar

Researching Early Detection of Ovarian and Endometrial Cancer using High Sensitivity Genomic Assays

DOvEEgene, shows promise as a screening test as it can detect prevalent endometrial/ovarian cancers as well as hereditary predisposition to these cancers in peri/postmenopausal women.
Registration is Closed
Researching Early Detection of Ovarian and Endometrial Cancer using High Sensitivity Genomic Assays

Time & Location

Jun 08, 2021, 10:00 AM CDT
webinar

Share this event